TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34757964

Group type: EXPERIMENTAL
Intervention: Various pharmacological interventions over the years including anticholinesterases (physostigmine, neostigmine), immunosuppressants (prednisone, azathioprine), intravenous immune globulin, mycophenolate, cyclosporine, tacrolimus, monoclonal antibodies (rituximab, eculizumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial interventions in 1927 included adequate feeding, absolute rest in bed, and tonics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ephedrine and glycine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunosuppressant pharmacological interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer immunosuppressant drugs (mycophenolate, cyclosporine, tacrolimus)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies (rituximab, eculizumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized clinical trial of drug therapy for myasthenia gravis
Number of subjects: 0
Study: 32217018

Group type: EXPERIMENTAL
Intervention: Latin Americans residing in Spain (group A)
Number of subjects: 2687

Group type: COMPARATOR
Intervention: Latin Americans residing in the United States (group B)
Number of subjects: 2687
Study: 36229663

Group type: EXPERIMENTAL
Intervention: Tebentafusp (gp100×CD3), a soluble T cell receptor bispecific
Number of subjects: 127
Study: 34473963

Group type: EXPERIMENTAL
Intervention: 1.3% liposomal and 0.25% plain bupivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.25% plain bupivacaine
Number of subjects: 120
Study: 33107110

Group type: EXPERIMENTAL
Intervention: Adiposity measures (BMI, waist circumference, subscapular skinfold, middle upper arm circumference)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: BMI (per kg/m2 increase)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Waist circumference (per cm increase)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Subscapular skinfold (per mm increase)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Middle upper arm circumference (per mm increase)
Number of subjects: 1200
Study: 34391298

Group type: EXPERIMENTAL
Intervention: Dual task group (DTG) - 16 dual task training sessions based on the Trail Making Test (TMT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (CG) - Conventional training protocol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dual task group (DTG)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 10
Study: 32893023

Group type: EXPERIMENTAL
Intervention: Connective Tissue Manipulation (CTM) combined with usual care
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Abdominal Massage combined with usual care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual Care Alone
Number of subjects: 60
Study: 35968511

Group type: EXPERIMENTAL
Intervention: 60 mg/day tandospirone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 mg/day tandospirone
Number of subjects: 0
Study: 33252553

Group type: EXPERIMENTAL
Intervention: Tiered prioritization list for orthopaedic procedures
Number of subjects: 63
Study: 35655360

Group type: EXPERIMENTAL
Intervention: Multilayer bags with a mixture of 83%N2 + 15%CO2 + 2%O2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (packages without gaseous and alcoholic paper)
Number of subjects: 0
Study: 33227558

Group type: EXPERIMENTAL
Intervention: Internet‐CBT
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 90
Study: 35868954

Group type: EXPERIMENTAL
Intervention: Outward preparatory gesture
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inward-upward preparatory gesture
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control conditions (animated bar and arrow)
Number of subjects: 18
Study: 34175270

Group type: EXPERIMENTAL
Intervention: Hybrid cardiac rehabilitation (CR; usual care) with an additional 3 months offered remotely based on the continuous care model
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (traditional 1-month supervised CR)
Number of subjects: 88
Study: 32632491

Group type: EXPERIMENTAL
Intervention: 0.01 mg/kg intravenous THC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg intravenous THC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (ethanol vehicle)
Number of subjects: 0
Study: 34891167

Group type: EXPERIMENTAL
Intervention: E-cigarette flavors (green apple, strawberry, chocolate, vanilla, menthol, koolada, peppermint, spearmint, subtle tobacco, full‐flavored tobacco) with nicotine formulations (free-base, salt)
Number of subjects: 119
Study: 33394598

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EN), specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Restrictive dose EN into the stomach after initial resuscitation, specific dosage not mentioned.
Number of subjects: 0
Study: 36123398

Group type: EXPERIMENTAL
Intervention: Fimasartan
Number of subjects: 341

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 341
Study: 33982511

Group type: EXPERIMENTAL
Intervention: Objective performance criteria in post-marketing evaluation of TCM injections
Number of subjects: 0
Study: 34601386

Group type: EXPERIMENTAL
Intervention: Hypnosis intervention (four weekly sessions plus treatment-as-usual)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 20
Study: 33010799

Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 35836919

Group type: EXPERIMENTAL
Intervention: Omaha system care group
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine care group
Number of subjects: 96
Study: 34363307

Group type: EXPERIMENTAL
Intervention: DTM SCS
Number of subjects: 128

Group type: COMPARATOR
Intervention: Traditional SCS
Number of subjects: 128
Study: 33586478

Group type: EXPERIMENTAL
Intervention: Asymptomatic proximal DVT
Number of subjects: 7036

Group type: EXPERIMENTAL
Intervention: Symptomatic VTE
Number of subjects: 7036

Group type: COMPARATOR
Intervention: No VTE
Number of subjects: 7036
Study: 32160420

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1767
Study: 35436976

Group type: EXPERIMENTAL
Intervention: Family systemic psychosocial support intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 34477330

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (480 mg/day)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 32292492

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cytosorb
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 76
Study: 36122646

Group type: EXPERIMENTAL
Intervention: Hyperoxia (FiO2 1.0)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypoxia (FiO2 ≈ 0.11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline (room air)
Number of subjects: 20
Study: 35450801

Group type: EXPERIMENTAL
Intervention: High omega-3LC group
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low omega-3LC group
Number of subjects: 46
Study: 33067169

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 800 mg
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 35807801

Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Lactobacillus acidophilus LA‐5, Lactiplantibacillus plantarum UBLP‐40, Bifidobacterium animalis subsp. lactis BB‐12, Saccharomycesboulardii Unique‐28)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 32340871

Group type: EXPERIMENTAL
Intervention: Usual-dose aspirin (325 mg)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Low-dose aspirin (81 mg)
Number of subjects: 321
Study: 34273468

Group type: EXPERIMENTAL
Intervention: Extreme weekly locoregional hypofractionated radiation (HFRT)
Number of subjects: 50
Study: 32307005

Group type: EXPERIMENTAL
Intervention: Statin cessation strategy
Number of subjects: 2430

Group type: COMPARATOR
Intervention: Continuing statin treatment at usual dosage
Number of subjects: 2430
Study: 34733238

Group type: EXPERIMENTAL
Intervention: GnRH agonist pretreatment
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control (no GnRH agonist pretreatment)
Number of subjects: 133
Study: 33022417

Group type: EXPERIMENTAL
Intervention: aPDT (Photodithazine, 200 mg/L, 6 sessions, 3 times a week for 15 days)
Number of subjects: 65

Group type: COMPARATOR
Intervention: NYS (nystatin, 1 dropper, 4 times a day for 15 days)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: aPDT
Number of subjects: 65

Group type: COMPARATOR
Intervention: NYS
Number of subjects: 65
Study: 36858761

Group type: EXPERIMENTAL
Intervention: Choice group (n = 77) - participants could choose one of the two digital programs
Number of subjects: 155

Group type: COMPARATOR
Intervention: No-choice group (n = 78) - participants assigned a program at random
Number of subjects: 155
Study: 33570770

Group type: EXPERIMENTAL
Intervention: Peak CK within 1st tertile (CK ≤259 U/L; n=1127 patients)
Number of subjects: 3368

Group type: EXPERIMENTAL
Intervention: Peak CK within 2nd tertile (CK 260 to 990 U/L; n=1119 patients)
Number of subjects: 3368

Group type: EXPERIMENTAL
Intervention: Peak CK within 3rd tertile (CK ≥991 U/L; n=1122 patients)
Number of subjects: 3368

Group type: EXPERIMENTAL
Intervention: Peak CK activity (adjusted)
Number of subjects: 3368
Study: 32453306

Group type: EXPERIMENTAL
Intervention: LCPT 2 mg (morning dosing)
Number of subjects: 2

Group type: COMPARATOR
Intervention: LCPT 2 mg (evening dosing)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: LCPT 5 mg (after high-calorie meal)
Number of subjects: 2

Group type: COMPARATOR
Intervention: LCPT (fasted state)
Number of subjects: 2
Study: 33579715

Group type: EXPERIMENTAL
Intervention: MiniMed Advanced Hybrid Closed-Loop (AHCL) system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy with predictive low glucose management (SAP + PLGM)
Number of subjects: 60
Study: 32916125

Group type: EXPERIMENTAL
Intervention: Epigenomic reprogramming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chromatin modifiers mutations
Number of subjects: 0
Study: 36307098

Group type: EXPERIMENTAL
Intervention: Sitting plus 2 min of moderate-intensity activity every 30 min (INT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Uninterrupted sitting (SIT)
Number of subjects: 14
Study: 32468396

Group type: EXPERIMENTAL
Intervention: STEPS (Stepped Transition in Education Program for Students with ASD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Transition as usual (TAU; waitlist control group)
Number of subjects: 32
Study: 616886745

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention combined with routine nursing care
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (routine nursing care only)
Number of subjects: 98
Study: 36331698

Group type: EXPERIMENTAL
Intervention: Dads Matter-HV intervention
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard home visiting services as usual (Control)
Number of subjects: 204
Study: 33656380

Group type: EXPERIMENTAL
Intervention: Training targeting working memory (WM)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Training targeting inhibitory control (IC)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Training targeting cognitive flexibility (CF)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Active control group (comparatively engaging and challenging, but did not train a specific EF)
Number of subjects: 160
Study: 32317724

Group type: EXPERIMENTAL
Intervention: Single-molecule real-time sequencing technology
Number of subjects: 0
Study: 33064065

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (HIIT)
Number of subjects: 32
Study: 34073024

Group type: EXPERIMENTAL
Intervention: L-carnitine injection three times weekly
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: L-carnitine injection once weekly
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 33337664

Group type: EXPERIMENTAL
Intervention: Fosphenytoin, levetiracetam, or valproate (specific intervention not detailed in the abstract)
Number of subjects: 475

Group type: COMPARATOR
Intervention: N/A (control group not specified)
Number of subjects: 475
Study: 33574495

Group type: EXPERIMENTAL
Intervention: Second-generation Laryngeal Mask Airway (LMA)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both LMA and ETT
Number of subjects: 88
Study: 32470492

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 0
Study: 35883034

Group type: EXPERIMENTAL
Intervention: Family-Centered Empowerment Model (FCEM) provided in four online sessions via WhatsApp messenger for two weeks after patient discharge.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 70
Study: 34510703

Group type: EXPERIMENTAL
Intervention: Salt meter plus dietary education (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Education only (group B)
Number of subjects: 90
Study: 32486525

Group type: EXPERIMENTAL
Intervention: RBC‐TPL
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: SAT
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both SAT depots
Number of subjects: 41
Study: 36124697

Group type: EXPERIMENTAL
Intervention: Vaccine-boosted
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Vaccinated with primary series only
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Unvaccinated
Number of subjects: 1062
Study: 35177320

Group type: EXPERIMENTAL
Intervention: Educational Animation Group (n = 44)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Documentary Group (n = 44)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control Group (n = 44)
Number of subjects: 132
Study: 34140345

Group type: EXPERIMENTAL
Intervention: 2+1 PCV13 schedule
Number of subjects: 20

Group type: COMPARATOR
Intervention: 3+0 PCV13 schedule
Number of subjects: 20
Study: 32291187

Group type: EXPERIMENTAL
Intervention: Percutaneous axial flow pumps
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 35552078

Group type: EXPERIMENTAL
Intervention: Passive heating (HT)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Thermoneutral control (TN)
Number of subjects: 4
Study: 34219190

Group type: EXPERIMENTAL
Intervention: Intravenous hypertonic saline (HTS) to achieve and maintain plasma sodium between 145 and 150 mmol/l for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HTS group
Number of subjects: 40
Study: 34365060

Group type: EXPERIMENTAL
Intervention: Toothpaste with Polish propolis, tea tree oil, menthol, and rosemary oil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo toothpaste without active ingredients
Number of subjects: 50
Study: 32671684

Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol 5/5 µg
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Tiotropium 5 µg
Number of subjects: 1078
Study: 35705981

Group type: EXPERIMENTAL
Intervention: Anopheles gambiae
Number of subjects: 15632

Group type: EXPERIMENTAL
Intervention: Anopheles funestus
Number of subjects: 15632

Group type: EXPERIMENTAL
Intervention: EIR for both species
Number of subjects: 15632

Group type: EXPERIMENTAL
Intervention: Anopheles coluzzii
Number of subjects: 15632
Study: 33707305

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (SGLT2is)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonists (GLP-1RAs)
Number of subjects: 3
Study: 35706448

Group type: EXPERIMENTAL
Intervention: Polygenic risk estimates (experimental group)
Number of subjects: 1363

Group type: COMPARATOR
Intervention: Traditional risk factors (control group)
Number of subjects: 1363
Study: 35266202

Group type: EXPERIMENTAL
Intervention: Pneumatic jet injection (PJI) with 5-fluorouracil (5-FU) and triamcinolone acetonide (TAC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 34427481

Group type: EXPERIMENTAL
Intervention: Intensive BP-lowering (systolic BP < 140 mmHg)
Number of subjects: 668

Group type: COMPARATOR
Intervention: Conventional BP-lowering (systolic BP 140-180 mmHg)
Number of subjects: 668
Study: 32084280

Group type: EXPERIMENTAL
Intervention: YAG vitreolysis treatment
Number of subjects: 35
Study: 35266281

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 50 U
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 75 U
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 100 U
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 125 U
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 33245125

Group type: EXPERIMENTAL
Intervention: Warning labels on SSB dispensers at the intervention site
Number of subjects: 840
Study: 35793948

Group type: EXPERIMENTAL
Intervention: Overminus lens therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no overminus lens therapy)
Number of subjects: 84
Study: 32635829

Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 12
Study: 32591562

Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA) 600 mg, one tablet a day
Number of subjects: 40
Study: 36085270

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 2849

Group type: COMPARATOR
Intervention: HRT cycle
Number of subjects: 2849

Group type: COMPARATOR
Intervention: Natural cycle
Number of subjects: 2849
Study: 35352176

Group type: EXPERIMENTAL
Intervention: Low-TOX (fractionated docetaxel, oxaliplatin, capecitabine)
Number of subjects: 169

Group type: COMPARATOR
Intervention: EOX (epirubicin, oxaliplatin, capecitabine)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Low-TOX
Number of subjects: 169

Group type: COMPARATOR
Intervention: EOX
Number of subjects: 169
Study: 34590247

Group type: EXPERIMENTAL
Intervention: FIFA 11+ with added neck exercises (5 weeks, 3 times per week)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual part 2 of the FIFA 11+ (no neck exercises)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: FIFA 11+ with added neck exercises
Number of subjects: 52
Study: 32605614

Group type: EXPERIMENTAL
Intervention: stimuli-relevant AATP + treatment as usual (TAU)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: stimuli-relevant AATP in virtual reality + TAU
Number of subjects: 204

Group type: COMPARATOR
Intervention: TAU only (control group)
Number of subjects: 204
Study: 35503089

Group type: EXPERIMENTAL
Intervention: Equitable sociocultural classroom interactions
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Equitable disciplinary and personalized learning practices
Number of subjects: 105
Study: 33909188

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus NCDC15 fermented milk with 8 g of Cichorium intybus root powder (LAC) along with basal diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri BFE7 fermented milk with 8 g of Cichorium intybus root powder (LRC) along with basal diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CON) provided with a basal diet alone
Number of subjects: 24
Study: 35461831

Group type: EXPERIMENTAL
Intervention: Aflibercept or bevacizumab
Number of subjects: 330
Study: 33764198

Group type: EXPERIMENTAL
Intervention: Inorganic nitrate therapy (12 mmol KNO3 capsules)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Placebo (potassium chloride capsules)
Number of subjects: 640
Study: 36241455

Group type: EXPERIMENTAL
Intervention: Q-PDN tool adapted to the French-Canadian context
Number of subjects: 0
Study: 32008990

Group type: EXPERIMENTAL
Intervention: Classic Kinesio Taping technique (technique A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: New Kinesio Taping technique (technique B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No Kinesio Taping (No-KT)
Number of subjects: 60
Study: 34412699

Group type: EXPERIMENTAL
Intervention: Active educational intervention (12 hours of EBP-structured presentation)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Passive educational intervention (daily rounds, journal clubs, morning reports)
Number of subjects: 69
Study: 32052995

Group type: COMPARATOR
Intervention: BWL (standard)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Stepped care
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Stepped care with medication
Number of subjects: 191

Group type: COMPARATOR
Intervention: Stepped care with placebo
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Stepped care (range)
Number of subjects: 191
Study: 35066899

Group type: EXPERIMENTAL
Intervention: Resveratrol (RSV) 1000 mg/day for 8 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 9
Study: 34031503

Group type: EXPERIMENTAL
Intervention: HDx with Theranova membrane
Number of subjects: 80

Group type: COMPARATOR
Intervention: online-HDF
Number of subjects: 80
Study: 34537386

Group type: EXPERIMENTAL
Intervention: Implementation Document (ID) for RoB2 tool
Number of subjects: 16

Group type: COMPARATOR
Intervention: Calibration exercise before ID adoption
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Time to apply RoB2 tool after ID adoption
Number of subjects: 16

Group type: COMPARATOR
Intervention: Time to apply RoB2 tool before ID adoption
Number of subjects: 16

Group type: COMPARATOR
Intervention: Calibration exercise and ID development time
Number of subjects: 16
Study: 34033228

Group type: EXPERIMENTAL
Intervention: Structured palliative care
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual supportive care
Number of subjects: 68
Study: 36316084

Group type: EXPERIMENTAL
Intervention: rhGAD65
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 33983755

Group type: EXPERIMENTAL
Intervention: Web-based relationship education programs
Number of subjects: 572

Group type: COMPARATOR
Intervention: Matched sample (did not break up)
Number of subjects: 572
Study: 32344842

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU/month for 6 months)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo pearls (control group)
Number of subjects: 71